BeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual Meeting
27 Setembro 2023 - 11:00AM
BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”),
a global clinical-stage biopharmaceutical company focused on using
a groundbreaking technology platform for drug discovery and
developing innovative therapies to improve clinical outcomes for
patients with high unmet medical needs, today announced the
presentation of a poster at the Society for Immunotherapy of
Cancer's (SITC) 38th Annual Meeting, taking place on November 3
through 5 in San Diego, CA.
The poster, titled, “Immune Activation with
Plinabulin Enhances Anti-tumor Response Combining Radiation with
Immune Checkpoint Blockade,” will be presented by Dr. Steven H.
Lin, MD., Ph.D., physician-scientist, radiation oncologist and
professor who specializes in thoracic malignancies at The
University of Texas MD Anderson Cancer Center.
Additional presentation details are as follows:
- Poster Session Date / Time: Saturday, November
4th, 2023, at 9 a.m. to 8:30 p.m. PDT
- Location: San Diego Convention Center, Exhibit
Halls A and B1
- Type of Presentation: Poster Presentation
- Abstract No.: 732
About BeyondSpringBeyondSpring
(NASDAQ: BYSI) is a global clinical-stage biopharmaceutical company
focused on developing innovative therapies to improve clinical
outcomes for patients with high unmet medical needs. The Company is
advancing its first-in-class lead asset, Plinabulin, as a direct
anti-cancer agent in various cancer indications and to prevent
chemotherapy-induced neutropenia. Its pipeline also includes three
preclinical immuno-oncology assets. Additionally, BeyondSpring’s
subsidiary, SEED Therapeutics, leverages a proprietary targeted
protein degradation (TPD) drug discovery platform and has an
initial R&D collaboration with Eli Lilly. Learn more by
visiting https://beyondspringpharma.com, and follow us
on LinkedIn and Twitter.
Investor
Contact:IR@beyondspringpharma.com
Media
Contact:PR@beyondspringpharma.com
BeyondSpring (NASDAQ:BYSI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
BeyondSpring (NASDAQ:BYSI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024